Immunome, Inc. (IMNM)
NASDAQ: IMNM · IEX Real-Time Price · USD
14.51
-0.18 (-1.23%)
May 2, 2024, 10:47 AM EDT - Market open
Immunome Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$34.00
Upside
+134.32%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +141.21% | Apr 15, 2024 |
Wedbush | Wedbush | Buy Maintains $27 → $33 | Buy | Maintains | $27 → $33 | +127.43% | Apr 1, 2024 |
Wedbush | Wedbush | Buy Maintains $12 → $19 | Buy | Maintains | $12 → $19 | +30.94% | Jan 23, 2024 |
Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | -17.30% | Dec 19, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | -44.87% | Mar 20, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | -44.87% | Mar 17, 2023 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 29, 2021 |
Chardan Capital | Chardan Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 27, 2020 |